Updated:
Intrinsic Capital Partners
Intrinsic Capital Partners is an investment firm focused on life science and technology businesses within the legal cannabinoid market. The Intrinsic team...
Intrinsic Capital Partners
Intrinsic Capital Partners is an investment firm focused on life science and technology businesses within the legal cannabinoid market. The Intrinsic team brings institutional investment discipline and world-class operating experience to build and scale industry-leading companies that address unmet needs across the supply chain.
General information
Firm type
Private Equity
Year founded
2000
Location
Region
North America
Country
United States
City
Conshohocken
Corporate office
Conshohocken, PA, United States
Sector focus
Frequently asked questions
Does Intrinsic Capital Partners invest across the entire cannabinoid supply chain?
Yes. The firm's public materials describe a focus on life-science and technology businesses that address unmet needs across the supply chain, from cultivation and processing through branded products and enabling infrastructure. Intrinsic does not publicly limit itself to a single vertical within the legal cannabinoid market.
What investment stages does Intrinsic Capital Partners target?
Intrinsic targets early-stage, expansion, late-stage, and growth-stage businesses. The firm's strategy covers venture-style positions through growth-equity commitments, always within the legal cannabinoid sector, but it has not disclosed a preferred check size or fund structure.
How does the firm differentiate its investing approach in the cannabinoid space?
Intrinsic emphasizes institutional investment discipline and operating experience, positioning itself to build and scale companies rather than function as a passive financial sponsor. The firm combines pharmaceutical-industry rigor with hands-on operational engagement, a posture that differs from both pure venture capitalists and large diversified private equity managers who treat cannabis as a side allocation.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: